HCV Treatment-Induced Anemia Predicted by Genetics
March 1, 2010
Enzyme Deficiency Protects Hepatitis C Patients from Treatment-Related Anemia
ScienceDaily (Feb. 24, 2010) — Many people who undergo treatment for hepatitis C develop hemolytic anemia, a disorder that destroys red blood cells. In some cases, it is so severe they have to reduce their medication or stop therapy altogether. But now, scientists in Duke University’s Institute for Genome Sciences & Policy (IGSP) have discovered two genetic alterations linked to a benign enzyme condition that keep some patients anemia-free.
Continue reading this entire article:
Easing Liver Inflammation: Balancing Omega-3's and Omega-6's
Altered Mice Offer Ideal Liver Disease Drug Testing Model